Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
20
×
life sciences
national blog main
clinical trials
boston blog main
boston top stories
fda
national top stories
boston
deals
san francisco blog main
amgen
eli lilly
new york blog main
alnylam pharmaceuticals
investing
roche
san diego blog main
san francisco top stories
blueprint medicines
cancer
cancer drugs
drugs
indiana blog main
indiana top stories
new york top stories
novartis
rare disease drugs
rna interference
san diego top stories
startups
alexion pharmaceuticals
alirocumab
avapritinib
calcitonin gene-related peptide
chronic migraine
detroit blog main
detroit top stories
dyne therapeutics
episodic migraine
What
drug
20
×
medicines
20
×
new
fda
ipo
therapeutics
approval
cancer
company
disease
genetic
million
research
approved
biotech
cholesterol
developing
lead
muscle
pharmaceuticals
ready
year
blueprint
brings
candidate
class
clinical
companies
data
deal
developed
development
diseases
dyne
hepatitis
infectious
latest
learning
long
lowering
Language
unset
Current search:
drug
×
biotech
×
medicines
×
@tech.eu
1 year ago
EU-backed healthcare project rolls out platform for federated learning in drug discovery
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks